106 related articles for article (PubMed ID: 8386088)
1. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile.
Malgouris C; Flamand F; Doble A
Eur J Pharmacol; 1993 Mar; 233(1):29-35. PubMed ID: 8386088
[TBL] [Abstract][Full Text] [Related]
2. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
3. Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin.
Schotte A; Leysen JE
Eur J Pharmacol; 1988 Jan; 145(2):213-6. PubMed ID: 2832189
[TBL] [Abstract][Full Text] [Related]
4. Identification of 5-HT2 receptors, alpha 1-adrenoceptors and amine release sites in rat brain by autoradiography with [125I]7-amino-8-iodo-ketanserin.
Schotte A; Leysen JE
Eur J Pharmacol; 1989 May; 172(2):99-106. PubMed ID: 2548884
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain.
Malgouris C; Flamand F; Doble A
Eur J Pharmacol; 1993 Mar; 233(1):37-45. PubMed ID: 8472747
[TBL] [Abstract][Full Text] [Related]
8. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
Sahin-Erdemli I; Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
[TBL] [Abstract][Full Text] [Related]
9. [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.
Fajolles C; Boireau A; Ponchant M; Laduron PM
Eur J Pharmacol; 1992 May; 216(1):53-7. PubMed ID: 1526254
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
Mizuta T; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):315-26. PubMed ID: 2761132
[TBL] [Abstract][Full Text] [Related]
11. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
Pranzatelli MR; Murthy JN; Pluchino RS
J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
[TBL] [Abstract][Full Text] [Related]
12. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
Hoyer D; Pazos A; Probst A; Palacios JM
Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
[TBL] [Abstract][Full Text] [Related]
14. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.
Hoyer D; Vos P; Closse A; Pazos A; Palacios JM; Davies H
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):226-30. PubMed ID: 2884572
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
16. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
Syvälahti E; Penttilä J; Majasuo H; Pälvimäki EP; Laakso A; Hietala J
Pharmacopsychiatry; 2006 Jan; 39(1):1-8. PubMed ID: 16453246
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557
[TBL] [Abstract][Full Text] [Related]
19. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.
Pazos A; Hoyer D; Palacios JM
Eur J Pharmacol; 1984 Nov; 106(3):531-8. PubMed ID: 6519174
[TBL] [Abstract][Full Text] [Related]
20. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
Schotte A; de Bruyckere K; Janssen PF; Leysen JE
Brain Res; 1989 Oct; 500(1-2):295-301. PubMed ID: 2481562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
